Prosecution Insights
Last updated: April 19, 2026

Genevant Sciences GmbH

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18268023 PEG LIPIDS AND LIPID NANOPARTICLES ALLEN, SARAH ELIZABETH 1637 Non-Final OA Jun 16, 2023
17771421 ORNITHINE TRANSCARBAMYLASE (OTC) CONSTRUCTS AND METHODS OF USING THE SAME MARVICH, MARIA 1634 Non-Final OA Apr 22, 2022
17290549 THERAPEUTIC METHODS POPA, ILEANA 1633 Non-Final OA Apr 30, 2021

Managing Genevant Sciences GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month